V ascular malformations occur in arterial, capillary, venous, and lymphatic vessels throughout the entire body. Advances in DNA sequencing capabilities have led to an extensive list of pathogenic loss, or gain, -of-function mutations that cause these diseases, as reviewed previously. 1, 2 Although specific mutations have been identified for many of these malformations, what is less understood is how a mutant cell, harboring one of these mutations, leads to malformation development and growth. More specifically, it is not known if a single mutation event is sufficient to form these malformations or if multiple different mutation events are necessary to form these complex and structurally abnormal vessels. In this study, we use an inducible mouse model to investigate this question of mutant endothelial cell (EC) lineage in a specific vascular disease, cerebral cavernous malformations (CCMs).
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CCMs are ectatic, capillary-venous vessels which are lined with a single layer of ECs and lack surrounding parenchymal cells. Disruption of the endothelial barrier within these slow-flow malformations leads to recurrent hemorrhages, seizures, and focal neurological deficits. CCMs develop after biallelic inactivating mutations in KRIT1/CCM1 (KREV1/RAP1A interaction trapped-1), 3, 4 OSM/CCM2 (Osmosensing scaffold for MEKK3), 5, 6 or PDCD10/CCM3 (Programmed cell death 10). 7 CCMs develop sporadically or through an autosomal-dominant pattern of inheritance. Harboring a germline loss-of-function mutation, patients develop the heritable form of disease when a second somatic mutation occurs in the single remaining functional CCM allele. The familial disease often results in 10s to 100s of CCMs developing in adolescent patients, whereas the sporadic form of disease typically presents as a solitary CCM in adult patients. This difference in lesion burden is analogous to Knudson's observations of tumor burden in sporadic and familial forms of pediatric retinoblastoma. 8 Knudson's 2-hit model, of the first mutation in germ cells and the second mutation occurring in somatic cells, has been used to explain CCM pathogenesis. DNA sequencing studies have identified these second somatic mutations, with low allele frequencies, in human CCM samples.
What remains unknown is if a single second somatic mutation is sufficient for CCM formation and precisely where the mutant cells reside within the complex cellular architecture of the vascular malformation. We combined the neonatal Ccm3 mouse model with a multicolor fluorescent reporter to label mutant ECs and directly observe how mutant cells contribute to CCM pathology.
Methods
The corresponding author will make all data, methods used in the analysis, and materials used to conduct the experiments available upon request. This material will be available at Duke University School of Medicine in Durham, North Carolina.
Please see Online Data Supplement for detailed methods.
Results

Visualization of Somatically Mutated ECs in CCMs With an Inducible CCM3 Mouse Model and Confetti Reporter
To study the development of CCMs with respect to the ECs that have acquired the second, somatic mutation, we combined an endothelial-specific, tamoxifen (TMX)-inducible cre recombinase (PDGFb-iCreERT2), 13 lox-P flanked and knockout Ccm3 alleles, 14 and the Brainbow2.1, hereafter referred to as confetti, reporter construct (R26R-Confetti) 15, 16 in a transgenic mouse ( Figure 1A Figure 1B ). We injected these transgenic mice (n=3) with a single, 2-μg dose of TMX on either postnatal day 3, 4, or 5 to induce transient cre recombinase activity ( Figure 1C ). After the single injection of TMX, a subset of ECs within the vascular network acquired the induced second somatic mutation (deletion) and led to CCM development. CCM-null ECs overexpress pMLC (phospho-myosin light chain). 17, 18 Because of the lack of a reliable antibody that recognizes Ccm3 and the desire to visualize a gain-of, rather than loss-of signal to mark the deletion of Ccm3, we used the increased phosphorylation of MLC as a secondary marker for Ccm3 loss. ECs lining CCMs exhibit high levels of pMLC and are labeled with one of the confetti colors; thus, recombination at both the Ccm3 and R26R-Confetti loci are observed in the same EC (Online Figure I) .
Inducible CCM mouse models have been used extensively, with high doses and often multiple injections of TMX, to generate a severe phenotype to investigate the molecular signaling of CCM pathogenesis [19] [20] [21] [22] [23] [24] [25] and efficacy of proposed therapeutics. [26] [27] [28] [29] Our approach was to more closely model the more severe familial form of the human disease, in which random second somatic mutations occur in a small population of ECs, by using a very low dose of TMX. We induced a modest phenotype with CCMs dispersed throughout the cerebellum and cerebral hemispheres ( Figure 1D ). The dispersed CCMs enabled us to visualize individual CCMs to infer mutant EC lineage ( Figure 1E ). Serial brain sections, confocal microscopy, and 3-dimensional (3D) reconstruction were used to characterize the entire volume of individual CCMs. The Z-series of confocal images from the same brain region of serial slices were aligned and concatenated into 3D reconstructions of CCMs across large brain volumes. It was imperative to visualize an entire CCM, rather than a single section, to more confidently draw conclusions of the mutant EC lineage. Despite the use of a vibratome to section the entire brain into 80-μm-thick slices, the sectioning process resulted in slight tissue loss between each slice, which is best demonstrated in a video of a rotating 3D reconstruction (Online Movie I). The loss of tissue during brain processing was greatly outweighed by the valuable information gathered by reconstructing images from adjacent slices to examine entire CCMs.
Clonal Dominance of Mutant ECs in CCMs
Representative CCM images for each confetti color demonstrate that CCMs are lined with a disproportionate number of ECs expressing the same confetti color (Figure 1F ) with the same dose of TMX on P3 (n=1). Serial brain slices of the P25 control mouse contained a fluorescent signal density of 1.3 confetti-labeled ECs per 1×10 6 μm 3 of cerebellar brain volume. This background confetti labeling during normal vascular development established the minimum value that could distinguish between chance recombination at the confetti locus and joint recombination of the Ccm3 and R26R-Confetti alleles. This density of confetti labeling of ECs was the threshold for either including or excluding the CCMs from the clonal analysis. As anticipated, we observed CCMs containing a fluorescent EC density less than the background confetti labeling measured in the control brain slices. The CCMs that contained a confetti-labeled EC density less than the control (nonlesion) samples are likely derived from mutant ECs in which the R26R-Confetti allele did not recombine to tag the mutant ECs with a color. We excluded 28 CCMs from the analysis; of the 28 CCMs excluded, 86% (24/28) contained 2 or fewer ECs labeled with any confetti color. With the great majority of these excluded CCMs consisting of only 2 or fewer labeled cells, these data, even if included, would have contributed very little toward determining whether or not clonal dominance occurs in lesion genesis.
The CCM and control (nonlesion) samples had approximately equal proportions of ECs expressing each of the confetti colors ( Figure 1J ). The frequency of the R26R-Confetti allele recombining to tag ECs with each of the confetti colors within CCMs was as follows: Red, 20.6%; Yellow, 38.9%; Green, 36.5%; and Cyan, 4.0%. This low rate of the R26R-Confetti allele tagging ECs with mCFP provided a rare event to more confidently conclude that multiple ECs expressing mCFP within a CCM are derived from a single mutant EC. Furthermore, the ability to detect mCFP in all samples enabled us to confidently conclude that there was no cre recombination event within the confetti locus in the unlabeled Figure 1K ). The clonal dominance of ECs tagged with the same confetti color was calculated, as the percentage of ECs labeled with the clonally dominant color when considering all ECs tagged with a confetti color within the CCM, to be 94±9% (n=42; Figure 1 L) . The disproportionate number of ECs tagged with the same confetti color in these malformations suggests clonal expansion of a mutant EC during CCM development.
Nearest Neighbor Analysis Validates the Clonal Dominance of Mutant ECs in CCMs
Although even a cursory calculation of the difference in percentage of ECs labeled with each confetti color within individual CCMs showed a strong clonal dominance of one color (somatic mutation), we sought a more rigorous statistical analysis of the data. We performed a nearest neighbor (NN) analysis of labeled ECs using CCM lesion, control (nonlesion) tissue, and computer-generated simulation datasets. The NN algorithm is a method for determining the 3D distance between each member of a dataset. From the perspective of a single data point, the NN algorithm calculates the distance to all of the other data points and then ranks the distances from closest to furthest. The algorithm continues to the next data point within the group until all of the NN distances have been calculated and ranked for each member of the dataset. We applied the NN algorithm to the 3D reconstructions of the entire CCMs gathered from confocal images of serial brain slices. We represented each EC labeled with the clonally dominant confetti color within a CCM as a point with x,y,z coordinates (Figure 2A ). The NN distances were calculated and ranked for a single EC in the CCM (visually depicted in Figure 2B ; Online Movie V). The NN algorithm continued to a second EC in the CCM (visually depicted in Figure 2C ; Online Movie V), until the NN distances for all of the ECs within the CCM were calculated. The NN distances for all of the ECs within this representative CCM are plotted as distance (μm) versus NN number ( Figure 2G , green data points).
The same NN algorithm was applied to serial brain slices of the control, Ccm3 ECs labeled with the same confetti color within the control brain slices were each represented with an x,y,z point, and the NN distances were calculated for comparison with the NN distances calculated for the CCM. Given the varying recombination frequencies of the 4 confetti colors ( Figure 1J ), each color was analyzed independently in both the CCM and control samples. Thus, the NN distances for nGFP-labeled ECs within the control brain slices are plotted because the representative CCM being analyzed contained clonally dominant ECs expressing nGFP ( Figure 2G ; black data points). Imaging experiments have the potential for experimenter bias to be introduced when selecting a region of tissue to study. For example, a control region of low confetti labeling would bias in favor of the heavily labeled CCMs. Thus, we deliberately imaged regions of the control brain that contained many ECs expressing all of the confetti colors within the field of view, but we also created a second control data set that was generated randomly by a computer program. Using the x, y, and z dimensions of the 3D reconstruction of the CCM images and the number of ECs labeled with the clonally dominant confetti color of the CCM, the computer code generated a control dataset by randomly assigning the same number of data points into the same 3D volume as the experimental sample. The NN analysis was performed with this randomly generated dataset and then the code repeated the process using the same input parameters for a total of 100 iterations. The average NN distances for 100 simulations are plotted ( Figure 2G, pink data points) .
Combining the NN analysis for a representative CCM, nonlesional control samples, and a computer-generated random simulation, the stark difference in the NN distances between the control and experimental groups strongly supports the hypothesis that the observed close proximity of the clonally dominant mutant ECs in the CCM is not due to random chance ( Figure 2G ).
Clonal Dominance Is Observed in CCMs Across All Confetti Colors
We performed the NN analysis for all CCM and control (nonlesion) samples; the NN distances are plotted as distance (μm) versus NN number for each of the 4 confetti colors ( Figure 3A through 3D ). All CCMs, regardless of the confetti color expressed by the ECs, contained a clonally dominant population of ECs whose close proximity in 3D was not observed in the control brain slices. The CCM and brain slice control NN distances were statistically different beginning with the first NN for the RFP groups (P<0.001), YFP groups (P<0.001), nGFP groups (P<0.001), and mCFP groups (P<0.001) as determined by a Mann-Whitney test. These very low P values are driven by the large number of NN distances involved in each comparison. As P values do not comment on the biological process of an observation, the more important result is the clear divergence of the CCM and control NN distances as the NN number increases ( Figure 3A through 3D). The clonally dominant ECs within each of the 42 individual CCMs analyzed were significantly closer in 3D space than their respective confetti color controls. This pattern of clonally dominant ECs was observed across different CCMs as well as different confetti colors and illuminates a fundamental process of clonal expansion of Ccm3-null ECs in CCM development. 
Clonal Expansion of Mutant ECs and Recruitment of Neighboring ECs Drives CCM Development
The increased number of confetti-labeled ECs lining CCMs, that is not observed in the control samples, supports a clonal expansion of mutant ECs during CCM formation. Upon closer inspection of the CCMs imaged, a difference in the EC composition of small (diameter <100 μm) and large (diameter >100 μm) CCMs emerged. Many of the small CCMs imaged were composed nearly entirely of ECs labeled with the same confetti color ( Figure 4A ). Small CCMs consisting almost exclusively of clonally dominant ECs suggests that the EC which acquired the second somatic mutation and was labeled with a confetti color proliferated to initiate malformation development. We analyzed a small CCM with multiple caverns, some visibly connected within a single brain slice, in which each cavern was lined with ECs tagged with RFP ( Figure 4A ). Interestingly, these serial brain slice images also suggest that multicavernous CCMs can develop from the same somatic mutation. A rotation of the 3D reconstruction of the confocal images more clearly demonstrates the high proportion or RFP-labeled ECs lining this multicavernous CCM (Online Movie VII). In a different mouse, we visualized a larger multicavernous CCM (largest diameter >200 μm) that contained both confetti-labeled and unlabeled ECs ( Figure 4B ). The unlabeled ECs appear as blank spaces within the vascular walls for the malformation. These unlabeled ECs within the CCM likely represent wild-type ECs that have been incorporated into the growing malformation. The possibility of these unlabeled ECs being Ccm3-null, having undergone cre recombination within the Ccm3 allele and not the R26R-Confetti allele, cannot be excluded. However, as demonstrated in the pMLC staining of CCMs (Online Figure I) , CCMs contain a mosaicism of mutant and wild-type ECs. The mosaicism of mutant and wild-type ECs has been previously shown with staining of human CCMs, 30 as well as human CCM DNA sequencing studies in which a small percentage of the total DNA reads detected the second somatic mutation of the mutant ECs within the CCM. [9] [10] [11] [12] In large CCMs, we observe the same clonal expansion of mutant ECs as was seen with the small CCMs, as well as the recruitment of unlabeled, presumably wild-type, neighboring ECs into the growing malformation. These 2 CCMs represent different stages along the spectrum of CCM development. This spectrum of CCM pathology is well demonstrated in the CCMs shown in Figure 1F . The smaller CCMs in the left half of the 3D reconstruction contain a proportionally higher number of mutant cells than the larger CCMs on the right half of the image. This observation is supported by analysis of all 42 CCM lesions showing that the density of clonally dominant, mutant ECs decreases as CCMs grow larger ( Figure 4C ). Taken together, we propose a model of CCM pathogenesis by which an EC acquires a second somatic mutation, undergoes clonal expansion through a gain in proliferative capacity, and recruits neighboring ECs as the size and complexity of the malformation increases ( Figure 4D ).
Discussion
Herein we report a microscopy-based mutant EC lineage study of CCMs in an inducible mouse model. Using the confetti reporter, serial brain sectioning, confocal microscopy, and 3D reconstructions, we visualized entire CCMs and investigated CCM development at the cellular level. We studied both single-cavern and multicavernous CCMs of varying sizes that contained clonally dominant mutant ECs labeled with the same confetti color. The NN analysis, comparing CCMs with non-CCM control brain slices and a computer simulation, determined that the large quantity of ECs labeled with the same confetti color in close 3D space that was seen in the CCMs could not be attributed to background confetti labeling during normal vascular development or random chance. These findings suggest that a single second somatic mutation is sufficient to seed the formation of a CCM. The final important observation from these studies was the incorporation of unlabeled, wild-type ECs into the growing CCMs. It appears that CCMs increase in size by incorporating wild-type ECs into the vessel wall of the malformation. We propose a model of CCM development by which an EC acquires a second somatic mutation, undergoes clonal expansion, and recruits neighboring ECs to expand the malformation. This study focused on CCMs developing from Ccm3 mutations, and additional studies are warranted to determine if the proposed mechanism of CCM development is conserved in malformations arising from Ccm1 and Ccm2 mutations.
These results are consistent with and build on the findings of several other research groups. Increased proliferation has been observed with astrocytes harvested from this inducible Ccm3 mouse model and maintained in cell culture for several days. 31 We published a DNA sequencing study of human CCMs in which one of the cases identified the somatic mutations of a surgically resected CCM, as well as a subsequent CCM that occurred later in the same anatomic location, presumably due to regrowth of a remnant of the original CCM. We found that both the initial and second CCM harbored the identical CCM3 somatic mutation. 11, 12 The formation of a second CCM from the same population of mutant ECs strongly supports our model of clonal expansion of a mutant EC in CCM development.
The frequency at which the somatic mutation can be detected in the CCMs is generally <10% of all the DNA sequencing reads. 12 The low detection rate of the acquired, somatic mutation from large human CCMs highlights the mosaicism of CCM-null and wild-type ECs, which was also visualized by immunohistochemistry of human CCMs. 30 However, sequencing surgically resected CCMs includes all of the different cell types present in the tissue and not Figure 1K . B, Large (diameter >100 μm), multicavernous CCM with a clonally dominant population of ECs labeled with YFP (yellow fluorescent protein) interspersed with unlabeled (appearing as blank spaces) ECs (scale bar: 100 μm). This CCM corresponds to CCM No 22 in Figure 1K . C, The mutant EC density (number of clonally dominant ECs per 10 5 μm 3 CCM volume) decreases as CCMs grow larger (n=42). D, Working model of CCM development in which a single, second somatic mutation leads to clonal expansion and subsequent recruitment of wild-type ECs into growing CCMs. October 26, 2018 solely the ECs lining the caverns. Furthermore, because only one allele will acquire the somatic mutation, the observed mutant allele frequency reflects one half of the mutant cell frequency. In contrast to these sequencing data, our imaging data specifically identifies the mutant ECs in the lesion. Thus, our data more accurately represents the number of mutant cells contributing to the CCM.
Our work has expanded this concept of EC mosaicism by using confocal microscopy to trace mutant ECs, with singlecell resolution, and observe the change in EC composition as CCMs develop. A pattern of CCM development emerged in which many of the small, recently formed CCMs consisted nearly entirely of clonally expanded mutant ECs, whereas the large, multicavernous CCMs consisted of both the clonally expanded mutant ECs as well as a second population of unlabeled ECs. These 2 stages of CCM development, clonal expansion and incorporation of wild-type ECs, may offer new opportunities for therapeutic intervention.
Although CCMs are not considered vascular tumors, the increase in proliferation and regrowth of a malformation suggests that CCM-null ECs acquire an aggressive phenotype which may be targeted with antiproliferative therapies. Work by others has targeted cell proliferation in the context of angiogenesis, with anti-angiopoietin-2 antibodies, and observed a reduction in CCM development in this neonatal CCM3 mouse model. 24 Additional studies of antiproliferative therapies, particularly those not directly targeting angiogenesis, may reveal a fundamental roles of CCM3 in both physiological and pathological conditions. Although the presence of wild-type ECs in CCMs has been inferred by the low mutant allele frequency observed in CCM tissue, the mechanism by which these ECs become incorporated in the growing malformation is completely unknown. As our understanding of this phenomena improves, we can use CCM mouse models like that of the current study to test therapeutics administered to disrupt the cellular signals involved in CCM incorporation of wild-type ECs.
In conclusion, this work is the first to provide visual evidence for clonal expansion of mutant ECs in the development of CCMs. By imaging the entire CCM volume with single-cell resolution, we captured the initial clonal burst of mutant ECs in small CCMs followed by the incorporation of wild-type ECs into the network of clonally dominant mutant ECs of larger CCMs. This work has illuminated the mutant EC lineage of CCMs and highlighted the need to further investigate the molecular mechanisms by which a single somatic mutation, within a single EC, leads to a large, functional vascular malformation that contains a mixed population of both mutant and wild-type cells.
